---
title: "DNA X amends 8-K to update disclosure on Series B preferred stock sale and note conversion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292237487.md"
description: "DNA X filed an amended Form 8-K to update disclosures on its Series B Preferred Stock financing. The company sold 929,864 shares for $2.5 million and canceled a $3.1 million convertible note. It expects to issue remaining shares by Aug. 14. Reported stockholders’ equity was approximately $3.8 million as of July 9, exceeding Nasdaq’s $2.5 million listing threshold, though formal compliance determination remains pending."
datetime: "2026-07-09T20:06:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292237487.md)
  - [en](https://longbridge.com/en/news/292237487.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292237487.md)
---

# DNA X amends 8-K to update disclosure on Series B preferred stock sale and note conversion

-   DNA X filed an amended Form 8-K to update disclosures on its Series B Preferred Stock financing and related charter changes. \* The filing reported the July 8 sale of 929,864 Series B Preferred shares for USD 2.5 million cash, also canceling USD 3.1 million under a convertible promissory note. \* The company expects to issue the remaining 416,667 subscribed shares by Aug. 14. \* It reported estimated stockholders’ equity of about USD 3.8 million as of July 9, above Nasdaq’s USD 2.5 million continued-listing threshold. \* Nasdaq’s formal compliance determination remained pending. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-032680), on July 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [SONM.US](https://longbridge.com/en/quote/SONM.US.md)

## Related News & Research

- [DNA X announces private placement of 1,346,531 Series B preferred shares for USD 8.1 million](https://longbridge.com/en/news/291551471.md)
- [DNA: Q2 2026 revenue dropped 48% year-over-year, with major autonomous lab contracts secured](https://longbridge.com/en/news/295007946.md)
- [Lucid Diagnostics wins Concert coverage policy for EsoGuard esophageal DNA test across client health plans](https://longbridge.com/en/news/294970219.md)
- [Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test | LUCD Stock News](https://longbridge.com/en/news/294970708.md)
- [Another tough quarter for Fiserv may lead to product changes](https://longbridge.com/en/news/295271718.md)